Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exosome Therapy in Heart Failure Patients with LVAD (RESTORATION)
NCT07883317Phase 1Not yet recruiting
- Start
- Jan 2027
- Primary completion
- Feb 2028
01
Overview
Phase 1, randomised, double-blind trial in heart failure (HF) (2 arms). Primary endpoint: Incidence of treatment-related serious adverse events at 28 days. Planned start Jan 2027; status: not yet recruiting.
02
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07883317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07883317.